NCT03023800

Brief Summary

Macular schisis associated with macular detachment is a one of the complications of high myopia. There is controversy in the primary treatment for this situation. This study will compare the effects of macular buckling + gas injection versus vitrectomy + internal limiting membrane peeling + gas tamponade in a cohort of highly myopic eyes with macular retinal detachment associated with macular schisis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

January 16, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 18, 2017

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2017

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 12, 2017

Completed
Last Updated

October 16, 2017

Status Verified

October 1, 2017

Enrollment Period

1.8 years

First QC Date

January 16, 2017

Last Update Submit

October 12, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Retinal re-attachment rate

    3 month

Secondary Outcomes (2)

  • Post-operative best corrected visual acuity

    12 month

  • Post-operative macular structure on optical coherance tomography

    12 month

Study Arms (2)

Buckle

EXPERIMENTAL

Macular buckling and intraocular gas (C3F8) injection.

Procedure: Macular buckling

Vitrectomy

ACTIVE COMPARATOR

Vitrectomy, internal limiting membrane peeling, and gas tamponade (C3F8).

Procedure: Vitrectomy

Interventions

Surgical procedures of macular buckling, drainage of aqueous fluid (0.1-0.2 ml) through limbal paracentesis, and inject gas ( C3F8 100%, 0.2ml-0.3ml) into vitreous body through pars plana, under systemic anesthesia.

Buckle
VitrectomyPROCEDURE

Surgical procedures of small gauge vitrectomy, internal limiting membrane peeling, and gas (C3F8, 14%) tamponage, under local or systemic anesthesia

Vitrectomy

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • axial length ≥ 26.5 mm or refractive error (spherical equivalent) ≥ 8.0 diopter
  • macular schisis
  • macular retinal detachment
  • evidence of posterior staphyloma on clinical examination

You may not qualify if:

  • severe macular scar
  • macular detachment which extended to the peripheral retina (i.e., extension beyond the major vascular arcades in more than one quadrant)
  • prominent vitreomacular traction
  • a history of vitrectomy or macular buckle
  • intraocular active hemorrhage or inflammation
  • any media opacity which precluded imaging or clinical evaluation of the macula

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center

Guangzhou, Guangdong, 510060, China

Location

MeSH Terms

Conditions

Retinoschisis

Interventions

Vitrectomy

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Ophthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Lin Lu, MD,PhD

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Fundus Disease Center

Study Record Dates

First Submitted

January 16, 2017

First Posted

January 18, 2017

Study Start

April 1, 2015

Primary Completion

January 30, 2017

Study Completion

October 12, 2017

Last Updated

October 16, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations